Antitrust Team Successfully Defends CargoSprint Against Competitor’s Allegations

Members of the firm’s antitrust team are representing CargoSprint LLC in defending against an antitrust lawsuit brought by CargoSprint’s competitor, PayCargo LLC. On November 4, 2019, U.S. District Judge Timothy C. Batten Sr. dismissed PayCargo’s complaint against CargoSprint, finding that PayCargo had failed to identify the relevant market it claims was injured as a result of allegedly anti-competitive conduct on the part of CargoSprint. Judge Batten granted PayCargo leave to amend its complaint but found there were several problems with the lawsuit. The team includes Mike Dashefsky, Steele Clayton, Dale Grimes, Nick Goldin and Gingie Yetter.

The case was outlined in the following publications:

CargoSprint develops smart software solutions to assist freight forwarders, cargo facilities, and truckers in the cargo process.

You Also May Be Interested In:

  • Represented Addus HomeCare Corporation (Nasdaq: ADUS) in four strategic acquisitions and in its underwritten public offering of 2.3 million shares of common stock in 2019.

    We represented Addus HomeCare Corporation (Nasdaq: ADUS) in four strategic acquisitions in 2019, including the acquisition of Hospice Partners of...
    Client Type: Public Company
  • Represented Serco Inc. in its definitive Asset Purchase Agreement to acquire Alion Science & Technology Corporation’s Naval Systems Business Unit, including its Canadian business and a small number of related contract operations, for $225 million. The acquisition, subject to regulatory approvals, is expected to close in the second half of 2019.¬†Serco Inc., a provider of professional, technology, and management services, will strengthen its presence in naval support with this acquisition, and will become a stronger integrated maritime solutions provider for the U.S Navy and other customers.

    We represented Serco Inc. in its acquisition of Alion Science & Technology Corporation's Naval Systems Business Unit, including its Canadian...
    Client Type: Private Company
  • Represented¬†a leading provider of 340B Drug Pricing Program services in its acquisition by a prescription benefit management subsidiary of a leading pharmacy healthcare provider

    We served as lead healthcare regulatory counsel, as well as provided antitrust, employee benefits and tax support, for a leading...
    Client Type: Private Company